Study
|
Year
|
3-OS (in %)
|
5-OS (in %)
|
Early mortality (patients)
|
---|
Bonner et. al.
|
2006
|
55
|
40*
|
11/211 (5%)
|
Huguenin et. al.
|
2004
|
59°
|
46
|
0/112 (0%)
|
Calais et. al.
|
1999
|
51
|
-
|
1/109 (1%)
|
Merlano et. al.
|
1996
|
38*
|
24
|
not reported
|
Adelstein et. al.
|
2000
|
37
|
28*
|
6/96 (6%)
|
Wendt et. al.
|
1998
|
49
|
-
|
4/256 (2%)
|
Brizel et. al.
|
1998
|
55
|
48*
|
1/56 (2%)
|
Al-Sarraf et. al.
|
1998
|
78
|
68*
|
1/78 (1%)
|
Data from Basel
|
1994-2007
|
54
|
47
|
9/167 (5%)
|
- Therapy before 2000
| |
43
|
33
| |
- Therapy after 2000
| |
65
|
61
| |
- °Survival after 2.5 years.
- *estimated value.